PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

PRISM BioLab Co.,LTD

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

PRISM BioLab Co.,LTD made a loss over the last year. PRISM BioLab Co.,LTD owes ¥0.24 for every ¥1 it owns. PRISM BioLab Co.,LTD made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Sep 2025.

P/E ratio

Loss

PRISM BioLab Co.,LTD made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.64

The share price is 2.64 times PRISM BioLab Co.,LTD's book value per share, higher than 75% of Healthcare companies in Japan.

Market cap

¥5.0 B

The total market value of all of PRISM BioLab Co.,LTD's shares at today's price (share price × number of shares), smaller than 80% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥1.9 B

What PRISM BioLab Co.,LTD would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥51.15

Net worth divided by the number of shares. The share price of ¥135.00 is 2.6 times this, which is the P/B above.

Return on equity (ROE)

-37.9%

PRISM BioLab Co.,LTD lost 37.9% of its shareholders' money over the last year, lower than 85% of Healthcare companies in Japan.

Owes vs Owns

0.24×

PRISM BioLab Co.,LTD owes ¥0.24 for every ¥1 it owns (low), lower than 70% of Healthcare companies in Japan.

Dividend yield

None

PRISM BioLab Co.,LTD does not currently pay a dividend.

Revenue growth

+122%

Revenue rose 122% in the year to Sep 2025, and grew 7% a year on average over 3 years.

Profit growth

Loss

PRISM BioLab Co.,LTD made a loss in each of the last two years.

Profit margin

-123.1%

PRISM BioLab Co.,LTD lost ¥123 for every ¥100 of revenue.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For PRISM BioLab Co.,LTD: ¥5.0 B ÷ ¥1.9 B (30 Jun 2026) = 2.6.

What is PRISM BioLab Co.,LTD's return on equity?

PRISM BioLab Co.,LTD lost 37.9% of its shareholders' money over the last year, lower than 85% of Healthcare companies in Japan.

How much does PRISM BioLab Co.,LTD owe compared with what it owns?

PRISM BioLab Co.,LTD owes ¥0.24 for every ¥1 it owns (low), lower than 70% of Healthcare companies in Japan.

Does PRISM BioLab Co.,LTD pay a dividend?

No. PRISM BioLab Co.,LTD does not currently pay a dividend.

Is PRISM BioLab Co.,LTD's revenue growing?

Revenue rose 122% in the year to Sep 2025, and grew 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.